Authorised Therapeutic use (Phase IV) iron deficiency anaemia

Intravenous iron to treat postoperative anaemia in older cardiac surgery patients: a randomized controlled trial (AGE ANAEMIA study)

Q: Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Q: Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

Q: How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Q: Who can join this trial?

This study is enrolling all sexes, 65+ years. The study team makes the final eligibility decision.

EU CTIS ID: 2024-515920-35-01

What this study is testing

To determine the effect of treatment of of postoperative iron deficiency anaemia with intravenous iron on disability at 90 days after cardiac surgery

Therapeutic use (Phase IV)

A plain-language read of the study's public EU CTIS listing. The study team confirms the details.

Who can take part

You may be able to join if

 Mentally competent with age ≥ 70 years  Elective AVR or CABG surgery (including AVR or CABG surgery combined with rhythm surgery, i.e. maze, pulmonary vein isolation and left auricular ear amputation)  Expected uncomplicated postoperative trajectory, defined as: - No inotropic agents or ventilation at time of final inclusion (POD 1) - Expected discharge to general ward at POD 1  Moderate postoperative IDA, defined as: - Hb between 85 and 110 g/L and - Ferritin <100 μg/L or - Iron saturation (TSAT) < 20%

You likely can't join if

 Medical history of iron overload/haemochromatosis  Medical history of liver cirrhosis or ALT/AST value in blood serum triple of normal value (female patients: ALT >120, AST >105 U/L. Male patients: ALT>150, AST>135 U/L)  Severe renal failure (eGFR<15ml/min/1.73m2)  Recent treatment with IVI (<12 weeks prior)  Serious or severe allergic reaction to IVI in medical history  Severe asthma or eczema in medical history (atopic constitution)

The study team makes the final eligibility decision.

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 65+ years. The study team makes the final eligibility decision.

Explore other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH)Heart failure Coronary artery disease

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.